(Q43254669)

17 November 2017

Human mesenchymal stem cells and immunosuppressive drug interactions in allogeneic responses: an in vitro study using human cells (English)

1 reference

17 November 2017

F Buron

1

1 reference

17 November 2017

H Perrin

2

1 reference

17 November 2017

C Malcus

3

1 reference

17 November 2017

O Héquet

4

1 reference

17 November 2017

O Thaunat

5

1 reference

17 November 2017

M-N Kholopp-Sarda

6

1 reference

17 November 2017

F T Moulin

7

1 reference

17 November 2017

E Morelon

8

1 reference

17 November 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

Transplantation Proceedings

17 November 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

17 November 2017

41

1 reference

17 November 2017

8

1 reference

17 November 2017

3347-3352

1 reference

Marrow stromal cells as stem cells for nonhematopoietic tissues

17 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Multilineage potential of adult human mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

The role of mesenchymal stem cells in haemopoiesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Mesenchymal stem cells in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Human mesenchymal stem cells modulate B-cell functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Immunosuppression by mesenchymal stromal cells: from culture to clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Role of mesenchymal stromal cells in solid organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Human mesenchymal stem cells and cyclosporin a exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Mesenchymal stem cells modulate immune responses combined with cyclosporine in a rat renal transplantation model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.08.030

10.1016/J.TRANSPROCEED.2009.08.030

7 January 2021

Identifiers

DOI

1 reference

17 November 2017

1 reference